Application of isothiazolinone as synergist of antibacterial drug
A technology of isothiazolinone and benzisothiazolinone, which is applied in the application field of synergists, can solve the problems of drug resistance and reduce the efficacy of antibacterial drugs, so as to reduce toxic and side effects, reduce drug costs, The effect of treating bacterial infection
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0022] In vitro combined susceptibility test (FIC assay) of methylisothiazolinone (MIT) combined with colistin sulfate (Colistin) against Escherichia coli and Salmonella.
[0023] 1 reagent
[0024] Methylisothiazolinone, colistin sulfate.
[0025] 2 strains
[0026] Clinical isolation of chicken Escherichia coli SD-02, clinical isolation of Salmonella pullorum AH-05.
[0027] 3 media
[0028] Nutrient Broth, Nutrient Agar.
[0029] 4 instruments
[0030] Constant temperature incubator, constant temperature shaker, micropipette.
[0031] 5 test method
[0032] 5.1 Determination of minimum inhibitory concentration (MIC)
[0033] (1) Firstly, the drug stock solution was diluted 10 times with broth to obtain a drug solution with a concentration of 256 μg / mL. Then carry out continuous two-fold dilution, take 100 μL of the diluted drug solution, and add them to the 1st to 11th wells of the microplate according to the concentration from high to low, and the corresponding con...
Embodiment 2
[0049] In vitro combined susceptibility test (FIC assay) of benzisothiazolinone (BIT) and enrofloxacin (EN) against Escherichia coli and Salmonella.
[0050] 1 reagent
[0051] Benzisothiazolinone, enrofloxacin.
[0052] 2 strains
[0053] Clinical isolation of chicken Escherichia coli SD-02, clinical isolation of Salmonella pullorum AH-05.
[0054] 3 media
[0055] Nutrient Broth, Nutrient Agar.
[0056] 4 instruments
[0057] Constant temperature incubator, constant temperature shaker, micropipette.
[0058] 5 test method
[0059] With embodiment 1.
[0060] 6 result judgment
[0061] With embodiment 1.
[0062] 7 results
[0063]
[0064] The FIC of benzisothiazolinone combined with enrofloxacin against Escherichia coli is 0.5.
[0065] The FIC of benzisothiazolinone combined with enrofloxacin against Salmonella was 0.5.
[0066] It can be seen from the above test results that benzisothiazolinone has a synergistic effect on the antibacterial effect of enrofloxa...
Embodiment 3
[0068] In vitro combined susceptibility test (FIC assay) of methylchloroisothiazolinone (CMIT) and neomycin sulfate (NEO) against Escherichia coli and Salmonella.
[0069] 1 reagent
[0070] Methylchloroisothiazolinone, neomycin sulfate.
[0071] 2 strains
[0072] Clinical isolation of chicken Escherichia coli SD-02, clinical isolation of Salmonella pullorum AH-05.
[0073] 3 media
[0074] Nutrient Broth, Nutrient Agar.
[0075] 4 instruments
[0076] Constant temperature incubator, constant temperature shaker, micropipette.
[0077] 5 test method
[0078] With embodiment 1.
[0079] 6 result judgment
[0080] With embodiment 1.
[0081] 7 results
[0082]
[0083] The FIC of the combination of methylchloroisothiazolinone and neomycin sulfate against Escherichia coli was 0.5.
[0084] The FIC of the combination of methylchloroisothiazolinone and neomycin sulfate against Salmonella was 0.5.
[0085] As can be seen from the above test results, methylchloroisothi...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


